Cargando…
Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport
BACKGROUND: Duchenne musclar dystrophy (DMD) is an X-linked recessive disease caused by mutations of dystrophin gene, there is no effective treatment for this disorder at present. Plasmid-mediated gene therapy is a promising therapeutical approach for the treatment of DMD. One of the major issues wi...
Autores principales: | Xiong, Fu, Xiao, Shaobo, Yu, Meijuan, Li, Wanyi, Zheng, Hui, Shang, Yanchang, Peng, Funing, Zhao, Cuiping, Zhou, Wenliang, Chen, Huanchun, Fang, Liurong, Chamberlain, Jeffrey S, Zhang, Cheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931604/ https://www.ncbi.nlm.nih.gov/pubmed/17617925 http://dx.doi.org/10.1186/1471-2202-8-50 |
Ejemplares similares
-
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials
por: Chamberlain, Jeffrey S., et al.
Publicado: (2023) -
The Study of the Intercellular Trafficking of the Fusion Proteins of Herpes Simplex Virus Protein VP22
por: Xue, Xiaodong, et al.
Publicado: (2014) -
Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery
por: Hersh, Jessica, et al.
Publicado: (2021) -
Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation
por: Benabdallah, Basma F, et al.
Publicado: (2013) -
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
por: Le Guiner, Caroline, et al.
Publicado: (2017)